Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREMED: Prevention of Macular Edema After Cataract Surgery
NCT01774474Phase 3Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Jul 2013
- Primary completion
- Nov 2016
- Modality
- Monoclonal Antibodies, Orthosteric Ligands
- Countries
- 7
01
Overview
Phase 3, randomised, open-label trial of bromfenac sodium, dexamethasone, triamcinolone acetonide and bevacizumab in cystoid macular edema (CME), sponsored by Maastricht University Medical Center+. Started Jul 2013; status: completed.
02
Drugs
bromfenac sodiumdexamethasonetriamcinolone acetonidebevacizumab
03
Conditions
cystoid macular edema (CME)
Beyond the preview
Go deeper on NCT01774474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01774474.